MDxHealth SA / Fundamentals
Income statement
- Net revenue
€54.64M - Cost of goods sold
€21.63M - Gross profit
€33.02M - SG&A expenses
€51.03M - R&D expenses
€7.48M - EBITDA
-€22.15M - D&A
€6.20M - EBIT
-€25.71M - Interest expenses
€11.27M - EBT
-€38.34M - Tax expenses
€36.04K - Net income
-€41.02M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€303.73K - Changes in working capital
-€1.43M - Operating cash flow
-€20.46M - Capex
€5.36M - Other investing cash flow
€648.65K - Net investing cash flow
-€4.72M - Total cash dividends paid
€0.00 - Issuance of common stock
€33.98M - Debt repayment
-€1.27M - Other financing cash flow
€30.92M - Net financing cash flow
€29.65M - Foreign exchange effects
€115.83K - Net change in cash
€4.59M - Cash at end of period
€28.07M - Free cash flow
-€15.10M
Balance sheet
- Cash and cash equivalents
€28.07M - Cash and short-term investments
€28.07M - Total receivables
€7.35M - Inventory
€2.46M - Other current assets
€1.26M - Total current assets
€39.14M - Property, plant & equipment
€8.38M - Goodwill
€30.82M - Intangible assets
€38.11M - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€77.31M - Total assets
€116.46M - Accounts payable
€7.68M - Short-term debt
€1.75M - Other current liabilities
€6.75M - Total current liabilities
€16.17M - Long-term debt
€33.20M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€51.78M - Total non-current liabilities
€84.98M - Total liabilities
€101.15M - Common stock
€148.48M - Retained earnings
-€274.43M - Other equity
-€402.40K - Total equity
€15.31M - Total liabilities and shareholders' equity
€116.46M
Company information
- Market capitalization
€85.63M - Employees
252 - Enterprise Value
€116.72M
Company ratios
- Gross margin
-
60.4% Much better than peer group: -594.0% - EBITDA margin
-
-40.5% Much better than peer group: -23,133.3% - EBIT margin
-
-47.1% Much better than peer group: -35,591.8% - EBT margin
-
-70.2% Much better than peer group: -22,957.5% - Net margin
-
-75.1% Much better than peer group: -22,303.4% - ROE
-
-267.9% Much worse than peer group: 1,031.9% - ROA
-
-35.2% Much better than peer group: -64.1% - Asset turnover
-
46.9% Much better than peer group: 19.4% - FCF margin
-
-47.3% Much better than peer group: -39,052.6% - FCF yield
-30.2% - Efficiency ratio
140.5% - Net sales per employee
-
€216.84K - Net income per employee
-
-€162.78K